SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-227340
Filing Date
2015-06-18
Accepted
2015-06-18 16:22:19
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d933897d10q.htm 10-Q 532971
2 EX-14.1 d933897dex141.htm EX-14.1 32754
3 EX-31.1 d933897dex311.htm EX-31.1 5791
4 EX-31.2 d933897dex312.htm EX-31.2 5804
5 EX-32.1 d933897dex321.htm EX-32.1 2986
6 EX-32.2 d933897dex322.htm EX-32.2 3019
  Complete submission text file 0001193125-15-227340.txt   3725326

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT life-20150331.xml EX-101.INS 406850
8 XBRL TAXONOMY EXTENSION SCHEMA life-20150331.xsd EX-101.SCH 36903
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20150331_cal.xml EX-101.CAL 52977
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20150331_def.xml EX-101.DEF 147976
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20150331_lab.xml EX-101.LAB 309944
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20150331_pre.xml EX-101.PRE 229672
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 15940400
SIC: 2836 Biological Products, (No Diagnostic Substances)